drugset / Trial / NCT01974284
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma
NaSingle-groupOpen-labelTreatment
Summary
We assess the effectiveness of percutaneous ethanol ablation for the treatment of thyroid cancer.
Timeline
- Start
- 2014-03
- Primary completion
- 2017-03-02
- Completion
- 2017-06-29
Outcome
Outcome not reported
Stopped (Enrollment): “Lack of patient enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ethanol | Other / unclassified | — | Other |